Adamas Pharmaceuticals Inc

Adamas Pharmaceuticals, Inc. operates as a pharmaceutical company, which engages in discovering chrono-synchronous therapies. It involves in the development and commercialization of therapeutics targe...

Read More

ADMS Performance At-A-Glance

RISK EFFICIENCY

1.63

Adamas Pharmaceuticals Inc's risk efficiency is 1.63, which is good. By comparison, the S&P500 is -0.43.

Increasing quickly  over the past 4 weeks.

DSCORE

5.47%

Adamas Pharmaceuticals Inc's dScore is 5.47% , which is more volatile than the S&P500 (2.74%).

GROWTH

91.16%

Adamas Pharmaceuticals Inc has grown by 91.16% over the past year.  By comparison, the S&P500 has lost -11.31%.

Remained steady over the past 4 weeks.